Evidence map›Paper›PMID 30894514›Full record

ArticleCell death & disease2019

Resveratrol inhibits decidualization by accelerating downregulation of the CRABP2-RAR pathway in differentiating human endometrial stromal cells.

Asako Ochiai, Keiji Kuroda, Rie Ozaki, Yuko Ikemoto, Keisuke Murakami, Joanne Muter, Akemi Matsumoto, Atsuo Itakura, Jan J Brosens, Satoru Takeda

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Resveratrol and Female Fertility: A Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Signaling via retinoic acid receptors mediates decidual angiogenesis in mice and human stromal cell decidualization.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Frontiers in immunology · 2024
    Article
  14. Article
  15. Review
  16. EGF, TGF-International journal of molecular sciences · 2023
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Asako OchiaiDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Juntendo University, Tokyo, 113-8421, Japan.
Keiji KurodaDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Juntendo University, Tokyo, 113-8421, Japan. kuroda@sugiyama.or.jp.
Rie OzakiDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Juntendo University, Tokyo, 113-8421, Japan.
Yuko IkemotoDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Juntendo University, Tokyo, 113-8421, Japan.
Keisuke MurakamiDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Juntendo University, Tokyo, 113-8421, Japan.
Joanne MuterThe Division of Biomedical Sciences, Clinical Science Research Laboratories, Warwick Medical School, Coventry, CV2 2DX, UK.
Akemi MatsumotoDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Juntendo University, Tokyo, 113-8421, Japan.
Atsuo ItakuraDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Juntendo University, Tokyo, 113-8421, Japan.
Jan J BrosensThe Division of Biomedical Sciences, Clinical Science Research Laboratories, Warwick Medical School, Coventry, CV2 2DX, UK.ORCID http://orcid.org/0000-0003-0116-9329
Satoru TakedaDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Juntendo University, Tokyo, 113-8421, Japan.
Juntendo University · JPCoventry (United Kingdom) · GBUniversity Hospitals Coventry and Warwickshire NHS Trust · GB

Funding

Wellcome Trust 212233/Z/18/ZWellcome Trust 2/2233/Z/18/2
6 · The paper itself

Abstract

Pregnancy critically depends on the transformation of the human endometrium into a decidual matrix that controls embryo implantation and placenta formation, a process driven foremost by differentiation and polarization of endometrial stromal cells into mature and senescent decidual cells. Perturbations in the decidual process underpin a spectrum of prevalent reproductive disorders, including implantation failure and early pregnancy loss, emphasizing the need for new therapeutic interventions. Resveratrol is a naturally occurring polyphenol, widely used for its antioxidant and anti-inflammatory properties. Using primary human endometrial stromal cell (HESC) cultures, we demonstrate that resveratrol has anti-deciduogenic properties, repressing not only the induction of the decidual marker genes PRL and IGFBP1 but also abrogating decidual senescence. Knockdown of Sirtuin 1, a histone deacetylase activated by resveratrol, restored the expression of IGFBP1 but not the induction of PRL or senescence markers in decidualizing HESCs, suggesting involvement of other pathways. We demonstrate that resveratrol interferes with the reprogramming of the retinoic acid signaling pathway in decidualizing HESCs by accelerating down-regulation of cellular retinoic acid-binding protein 2 (CRABP2) and retinoic acid receptor (RAR). Notably, knockdown of CRABP2 or RAR in HESCs was sufficient to recapitulate the anti-deciduogenic effects of resveratrol. Thus, while resveratrol has been advanced as a potential fertility drug, our results indicate it may have detrimental effects on embryo implantation by interfering with decidual remodeling of the endometrium.

Indexed as

Cell DifferentiationCells, CulturedDeciduaDown-RegulationEmbryo ImplantationFemaleHumansLuteal PhasePregnancyReceptors, Retinoic AcidResveratrolRetinoic Acid Receptor alphaRNA InterferenceSignal TransductionStromal CellsTretinoinRARA protein, humanReceptors, Retinoic AcidResveratrolretinoic acid binding protein II, cellularRetinoic Acid Receptor alphaTretinoin

Identifiers

PMID30894514
PMCPMC6427032
OpenAlexW2922781616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.